pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 5·1 min read
save

BioNTech plans to cut up to 1,860 manufacturing jobs as it scales down production footprint

May 5, 2026·read at Endpoints ↗LayoffsNegative

BioNTech announced in its first‑quarter earnings release that it will reduce its manufacturing footprint.

The company said the restructuring could affect as many as 1,860 employees working in its production facilities.

The move reflects a strategic shift to align capacity with demand, but it raises concerns for the workforce and local economies.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “BioNTech to scale down manufacturing, over 1,800 jobs on the line”

read at Endpoints ↗
78 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoCDC page supporting Covid vaccines for pregnancy went darkEndpoints
  • 5h agoVirginia leads in winning investments as drugmakers onshore to the USEndpoints
  • 7h agoAstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumorsEndpoints
  • 7h agoNorthStar's China CRO deal; Lonza details midterm guidanceEndpoints
  • 8h agoOsivax pivots to combo approach after flu jab fails in Phase 2bEndpoints